The Scientist

» health care and culture

Most Recent

image: Book Excerpt from <em>The Creativity Crisis</em>

Book Excerpt from The Creativity Crisis

By | January 7, 2015

In Chapter 1, “Yin and Yang,” author Roberta B. Ness explores the dynamic tension between innovation and risk aversion in science past and present.

1 Comment

image: Capsule Reviews

Capsule Reviews

By | January 1, 2015

Does Altruism Exist?, Ancestors in Our Genome, Fred Sanger—Double Nobel Laureate, and Stiffs, Skulls & Skeletons

0 Comments

image: Innovation Renovation

Innovation Renovation

By | January 1, 2015

Is the fear of funding and doing fundamental, risky research killing our ability to make breakthroughs?

3 Comments

image: Speaking of Science

Speaking of Science

By | January 1, 2015

January 2015's selection of notable quotes

2 Comments

image: Pharma and Biotech Firms Hacked

Pharma and Biotech Firms Hacked

By | December 2, 2014

Cyberspies have broken into the e-mails of a number of publicly traded companies, most of which are in health care and pharmaceuticals.

0 Comments

image: Book Excerpt from <em>One Plus One Equals One</em>

Book Excerpt from One Plus One Equals One

By | December 1, 2014

In Chapter 7, “Green Evolution, Green Revolution,” author John Archibald describes how endosymbiosis helped color the Earth in a verdant hue.

0 Comments

image: Capsule Reviews

Capsule Reviews

By | December 1, 2014

Your Atomic Self, Eureka!, A Talent for Friendship, and Undeniable

0 Comments

image: Culturing Drug-Resistant Tumors

Culturing Drug-Resistant Tumors

By | November 17, 2014

Improved methods to grow patients’ tumor cells in a dish offer opportunities to find durable therapies.

1 Comment

image: The End of Science Sexism?

The End of Science Sexism?

By | November 5, 2014

A study suggests that, at least in US academia, men and women now receive roughly equivalent treatment in the workplace. The scientific community disagrees.

0 Comments

image: LabCorp Buys CRO

LabCorp Buys CRO

By | November 4, 2014

The $6 billion deal marks yet another massive transaction in the health-care industry.

1 Comment

Popular Now

  1. A Coral to Outlast Climate Change
  2. Antarctica Is Turning Green
  3. First In Vivo Human Genome Editing to Be Tested in New Clinical Trial
  4. How to Tell a Person’s “Brain Age”
AAAS